CBAN vs PDLB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CBAN presents a conflicting profile characterized by a very weak Piotroski F-Score of 2/9, indicating significant deterioration in fundamental financial health. While the stock trades below its Graham Number ($25.44) and maintains a reasonable P/E of 12.43, the divergence between strong revenue growth (33.9%) and stagnant earnings growth (2.4%) is concerning. Technical trends are heavily bearish (10/100), offsetting the 'Strong Buy' analyst consensus. Overall, the valuation is attractive, but the underlying financial health metrics suggest high operational risk.
PDLB presents a compelling value opportunity, trading at $17.53, which is below both its Graham Number ($19.29) and its growth-based Intrinsic Value ($35.4). While the Piotroski F-Score of 4/9 indicates only stable financial health and ROE is relatively low for the banking sector, the company is experiencing explosive earnings growth (264.10% YoY) and consistent earnings beats. The primary headwinds are technical and sentimental, as evidenced by a bearish technical trend and minimal insider buying. Fundamentally, the stock is undervalued relative to its current growth trajectory.
Compare Another Pair
Related Comparisons
CBAN vs PDLB: Head-to-Head Comparison
This page compares Colony Bankcorp, Inc. (CBAN) and Ponce Financial Group, Inc. (PDLB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.